Cogent Biosciences COGT
NASDAQ COGT
$31.02 -0.57 (-1.80%)
At close: Oct 2, 2026 · 4:00 PM EDT

Cogent Biosciences (COGT) Non-Current Deffered Revenue (2017 - 2018)

Updated

Cogent Biosciences' Non-Current Deffered Revenue came in at -$3.98 million for Q3 2018.

Analysis

Cogent Biosciences (COGT) Non-Current Deffered Revenue (2017 - 2018) Analysis & Trends

At the end of FY2017, Cogent Biosciences' Non-Current Deffered Revenue was $8.71 million.

  • Business Quant data shows COGT's Non-Current Deffered Revenue at $346,000 (Q2 2018), $3.66 million (Q1 2018) and $8.71 million (Q4 2017) in the three quarters before Q3 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Cogent Biosciences 5.49 Bn 5.49 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2018 -3.98 Mn
Jun 30, 2018 346,000.00
Mar 31, 2018 3.66 Mn
Dec 31, 2017 8.71 Mn
API Access

Cogent Biosciences Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=COGT&period=max&api_key=YOUR_API_KEY